Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit
Peter Schellongowski(Medical University of Vienna), Alexander Carlström(Comprehensive Cancer Center Vienna), Philipp Wohlfarth(Medical University of Vienna), Marija Bojić(Medical University of Vienna), Oliver Robak(Medical University of Vienna), Andja Bojic(Comprehensive Cancer Center Vienna), Thomas Staudinger(Northwestern University), Werner Rabitsch(Medical University of Vienna), Maria Obiditsch(Vienna General Hospital), Wolfgang R. Sperr(Medical University of Vienna), Paul Knoebl(Medical University of Vienna), Valentin Fuhrmann(University Medical Center Hamburg-Eppendorf), Klaus Laczika(Austrian Atherosclerosis Society), Katharina Riss(Comprehensive Cancer Center Vienna), Alexander Hermann(Universitätszahnklinik Wien), Gottfried J. Locker(Austrian Atherosclerosis Society)
Cited by 67
Related Papers
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
International Liver Transplant Society Practice Guidelines
|Transplantation|2016|440